Severance Hospital Yonsei University Health System ( Site 2201)

Seoul 03722

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Chronic Lymphocytic Leukaemia, Hematologic Malignancies, Non-Hodgkins Lymphoma, Waldenstroms Macroglobulinaemia

Studies at this site

• Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) — Recruiting now
• Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) — Running, not enrolling